LDH, lactate dehydrogenase
GHK-Cu is fully endogenous, present in human plasma, saliva, and urine, and released at sites of tissue injury through breakdown of SPARC and type I collagen
SASP inflammatory signaling declines
The peptide reduces production of pro-inflammatory cytokines including IL-1, TNF-, and IL-6 while enhancing expression of anti-inflammatory mediators such as IL-10 and TGF-, creating a cytokine milieu that supports tissue repair rather than ongoing damage
At first, you might need shots more often
The distinction matters because these two categories of treatment target the body in completely different ways, and confusing them leads to patients choosing the wrong protocol for their actual concern